DOCS financial statements and SEC filings
DOCS annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2026-03-31 | $644.86M | $214.92M | $196.05M | 10-K |
| 2025-03-31 | $570.40M | $227.80M | $223.19M | 10-K |
| 2024-03-31 | $475.42M | $163.88M | $147.58M | 10-K |
| 2023-03-31 | $419.05M | $125.11M | $112.82M | 10-K |
| 2022-03-31 | $343.55M | $113.54M | $133.26M | 10-K |
| 2021-03-31 | $206.90M | $53.30M | $21.56M | 10-K |
DOCS annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2026-03-31 | $1.12B | $172.85M | $950.84M | 10-Q |
| 2025-03-31 | $1.26B | $181.68M | $1.08B | 10-K |
| 2024-03-31 | $1.08B | $177.98M | $901.40M | 10-K |
| 2023-03-31 | $1.14B | $170.77M | $966.12M | 10-K |
| 2022-03-31 | $991.36M | $112.76M | $878.59M | 10-K |
| 2021-03-31 | $251.72M | $103.52M | $66.74M | 10-K |
DOCS annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2026-03-31 | $326.46M | $0.00 | -$464.06M | 10-K |
| 2025-03-31 | $273.26M | $0.00 | -$131.14M | 10-K |
| 2024-03-31 | $184.10M | -$147.00K | -$276.52M | 10-K |
| 2023-03-31 | $179.60M | -$1.70M | -$74.46M | 10-K |
| 2022-03-31 | $126.58M | -$1.91M | $560.41M | 10-K |
| 2021-03-31 | $82.97M | -$245.00K | $5.41M | 10-K |